2022
Dataset for the Reporting of Gestational Trophoblastic Neoplasia: Recommendations From the International Collaboration on Cancer Reporting (ICCR)
Hui P, Webster F, Baergen RN, Buza N, Cheung ANY, Kaur B, Ronnett BM, Shih IM, Seckl MJ, Lax SF, McCluggage WG. Dataset for the Reporting of Gestational Trophoblastic Neoplasia: Recommendations From the International Collaboration on Cancer Reporting (ICCR). International Journal Of Gynecological Pathology 2022, 41: s34-s43. PMID: 36305533, DOI: 10.1097/pgp.0000000000000876.Peer-Reviewed Original ResearchConceptsGestational trophoblastic neoplasiaTrophoblastic neoplasiaCancer reportingPathologic parametersTumor stagingCancer sitesPathology reportsPatient managementPatient careNeoplasiaNoncore elementsStagingTumor classificationPathologyInternational expertsDifferent populationsReportingCancer datasetsInternational collaboration
2021
Gestational Trophoblastic Neoplasms
Hui P. Gestational Trophoblastic Neoplasms. 2021, 791-820. DOI: 10.1007/978-3-030-84725-8_29.Peer-Reviewed Original ResearchEpithelioid trophoblastic tumorPlacental site nodulePlacental site trophoblastic tumorExaggerated placental site reactionAtypical placental site noduleGestational trophoblastic neoplasiaTrophoblastic tumorGestational choriocarcinomaPersistent gestational trophoblastic neoplasiaEarly chemotherapeutic interventionGestational trophoblastic tumorsGestational trophoblastic neoplasmsBenign reactive conditionsDistinct neoplastic entitySite reactionsTrophoblastic neoplasiaIntermediate trophoblastTrophoblastic neoplasmsPathological diagnosisPrecursor lesionsAncillary studiesNeoplastic entitiesPatient managementHigh indexHistological characteristics
2020
Heterozygous/dispermic complete mole confers a significantly higher risk for post-molar gestational trophoblastic disease
Zheng XZ, Qin XY, Chen SW, Wang P, Zhan Y, Zhong PP, Buza N, Jin YL, Wu BQ, Hui P. Heterozygous/dispermic complete mole confers a significantly higher risk for post-molar gestational trophoblastic disease. Modern Pathology 2020, 33: 1979-1988. PMID: 32404958, DOI: 10.1038/s41379-020-0566-4.Peer-Reviewed Original ResearchConceptsNon-molar gestationsGestational trophoblastic diseaseTrophoblastic diseaseHigh riskGestational trophoblastic neoplasiaProducts of conceptionPatient demographicsClinical followClinical outcomesGynecology HospitalTrophoblastic neoplasiaBeijing ObstetricsFIGO criteriaChinese patientsClinical prognosisPatient managementLarge cohortGestationMolar gestationDiseaseGenetic abnormalitiesChromosomal monosomyChromosomal aneuploidyHydatidiformUniparental disomy